Related Experiment Video
Updated: Aug 5, 2025

09:01
Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis
Published on: November 17, 2020
7.2K
Systemic relapses of primary CNS lymphomas (PCNSL): a LOC network study
J Dufour1, S Choquet2, K Hoang-Xuan1
1Hôpital Pitié-Salpêtrière, Service de Neurologie 2-Mazarin, APHP, Sorbonne Université, IHU, ICM, Paris, France.
Annals of Hematology
|March 29, 2023
Summary
Extracerebral relapses of primary CNS lymphoma (PCNSL) are rare, affecting 1.5% of patients. These often involve visceral organs like the testis and breast, with a poorer prognosis for mixed CNS and systemic relapses.
Area of Science:
- Neurology
- Oncology
- Pathology
Background:
- Primary CNS lymphomas (PCNSL) typically remain confined to the central nervous system.
- The behavior and characteristics of extracerebral relapses in PCNSL are not well understood.
Purpose of the Study:
- To analyze the incidence, characteristics, and outcomes of rare extracerebral relapses in PCNSL.
- To identify factors associated with survival in patients experiencing systemic relapse.
Main Methods:
- Retrospective nationwide population-based study using the French LOC database.
- Inclusion of 1968 PCNSL patients diagnosed from 2011 onwards.
- Analysis of 30 patients (1.5%) with confirmed extracerebral relapse, including histological confirmation in 20 cases.
Main Results:
- Extracerebral relapse occurred in 1.5% of PCNSL patients, with a median delay of 15.5 months.
- Common sites of relapse included visceral organs (77%), lymph nodes (40%), and peripheral nervous system (23%), with notable involvement of testis and breast.
- Median progression-free survival was 7 months and overall survival was 12 months post-relapse; higher KPS and pure systemic relapses correlated with better OS.
Conclusions:
- Extracerebral PCNSL relapses are uncommon, predominantly extranodal, and frequently involve specific organs like the testis, breast, and PNS.
- Mixed CNS and systemic relapses indicate a worse prognosis.
- Systematic PET-CT screening at diagnosis is recommended to detect potential occult extracerebral disease.
Related Concept Videos
Primary Lymphoid Organs
2.0K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
2.0K
Secondary Lymphoid Organs
1.8K
Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
1.8K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K

